Dr. David Fulton, a vascular biologist and faculty member in the Vascular Biology Center at the Medical College of Georgia at Georgia Regents University for more than a decade, is the center’s new Director.

Fulton, a Professor in the MCG Department of Pharmacology and Toxicology, has served since 2011 as Interim Director of the 18-year-old center which focuses on cellular and integrated mechanisms underlying blood vessel and cardiovascular function in normal and disease states.

“David has done a tremendous job building on the strengths of the Vascular Biology Center during his tenure as Interim Director,” said Dr. Peter F. Buckley, MCG Dean. “He has recruited additional scientists who are working closely with our physicians to ensure that their laboratory studies translate to better care for patients with vascular problems such as heart disease and sickle cell disease. He also has ventured into new areas for the center such as vascular inflammation and cardiac function.”

“We are extremely excited about David’s ability to continue to accelerate the scope and impact of our research on cardiovascular disease, the number one killer in our state and nation,” said Dr. Mark Hamrick, GRU Senior Vice President for Research. “We thank VBC’s founding Director John Catravas for building such a strong foundation.”

Fulton plans to recruit more top investigators in areas such as lung biology and metabolism and obesity, increase faculty participation in national activities such as cardiovascular study sections of the National Institutes of Health and American Heart Association, aid development of a cardiovascular research facility that enhances collaboration and expand undergraduate, graduate and postgraduate training of future scientists.

Fulton chairs the American Heart Association Vascular Endothelial Biology Review Committee. He is Associate Editor of the journal Frontiers in Oxidant Biology and an editorial board member of the American Journal of Physiology/Heart and Circulatory Physiology, Arteriosclerosis, Thrombosis and Vascular Biology and Circulation Research.

Fulton came to MCG in 2001 from Yale University where he completed postdoctoral training in pharmacology followed by a year as a research associate. He earned a Ph.D. in pharmacology from New York Medical College.

He studies molecular mechanisms regulating the function of vascular endothelium, the lining of the blood vessels, in health and disease. Normal vascular endothelium function is disrupted in diabetes and other cardiovascular disease such as acute lung injury.